Chemoprotectives - Cardioprotective Intracellular Chelators

Chemoprotectives – Cardioprotective Intracellular Chelators is a specialized, database-defined subclass of chemoprotective agents represented primarily by dexrazoxane These agents readily enter myocardial cells and hydrolyze into active chelating metabolites that bind intracellular iron, preventing the formation of toxic iron–anthracycline complexes and reducing reactive oxygen species generation, while also inhibiting topoisomerase II beta In clinical oncology, this therapeutic category is util...

Chemoprotectives – Cardioprotective Intracellular Chelators is a specialized, database-defined subclass of chemoprotective agents represented primarily by dexrazoxane In clinical oncology, this therapeutic category is utilized to prevent and mitigate cumulative, dose-dependent anthracycline-induced cardiotoxicity and cardiomyopathy, most notably in patients undergoing chemotherapy for advanced or metastatic malignancies such as breast cancer

These agents readily enter myocardial cells and hydrolyze into active chelating metabolites that bind intracellular iron, preventing the formation of toxic iron–anthracycline complexes and reducing reactive oxygen species generation, while also inhibiting topoisomerase II beta

These agents readily enter myocardial cells and hydrolyze into active chelating metabolites that bind intracellular iron, preventing the formation of toxic iron–anthracycline complexes and reducing reactive oxygen species generation, while also inhibiting topoisomerase II beta In clinical oncology, this therapeutic category is utilized to prevent and mitigate cumulative, dose-dependent anthracycline-induced cardiotoxicity and cardiomyopathy, most notably in patients undergoing chemotherapy for a...